NCT01809756View on ClinicalTrials.gov

The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy

NATerminatedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

February 25, 2014

Primary Completion Date

June 1, 2016

Study Completion Date

June 1, 2016

Conditions

Small Cell Lung CancerNon Small Cell Lung Cancer

Interventions

OTHER

Caphosol

Caphosol 4 times a day

Trial Locations (2)

4818 CK

Amphia Hospital, Breda

3015AA

Erasmus Medical Centre, Rotterdam

Sponsors

Collaborators (1)

Erasmus Medical Center

All Listed Sponsors

collaborator

Erasmus Medical Center

OTHER

lead

Amphia Hospital

OTHER

NCT01809756 - The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy | Biotech Hunter | Biotech Hunter